MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

SB225002

CAS No. : 182498-32-4

MCE 站：SB225002

产品活性：SB225002 是一种有效的选择性 CXCR2 非肽拮抗剂，抑制 ¹²⁵I-IL-8 和 CXCR2 结合的 IC₅₀ 为 22 nM。

研究领域：GPCR/G Protein  |  Immunology/Inflammation

作用靶点：CXCR

In Vitro: SB225002 (SB 225002) is an antagonist of ¹²⁵I-IL-8 binding to CXCR2 with an IC₅₀=22 nM. SB225002 shows >150-fold selectivity over CXCR1 and four other 7-TMRs tested. SB225002 is a potent antagonist of rabbit CXCR2, inhibiting rabbit PMN chemotaxis in response to optimal concentrations of human IL-8 or GROα (IC₅₀ values of 30 and 70 nM, respectively. In these cells (PMN, HL60, CXCR1-RBL-2H3), SB225002 produces a concentration-dependent inhibition of both IL-8- and GROα-mediated calcium mobilization with IC₅₀ values of 8 and 10 nM, respectively. In 3ASubE cells stably transfected with CXCR2, SB 225002 dose-dependently inhibits calcium mobilization induced by both GROα and IL-8, with IC₅₀ values of 20 and 40 nM, respectively. WHCO1 cells treated with SB225002 exhibits a 40% reduction in cell proliferation. Blocking CXCR2 signaling in WHCO1 cells with 400 nM SB225002 (SB 225002) significantly decreases cell proliferation by ~40% to 50%.

In Vivo: SB225002 (SB 225002) selectively blocks IL-8-induced neutrophil margination in rabbits. CXCR2 is blocked using the selective antagonist SB225002 (2 mg/kg) or neutralizing CXCR2 antiserum. The CXCR2 antagonist SB225002 decreases neutrophil counts in ischemic hemispheres of ApoE^?/? mice on Western diet and wildtype mice on normal diet. SB225002 significantly attenuates microglial activation and BBB damage, increases myelination, and reduces astrogliosis in the white matter after LPS-sensitized HI.

相关产品：Covalent Screening Library Plus  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Immunology/Inflammation Compound Library  |  Anti-Cancer Compound Library  |  Small Molecule Immuno-Oncology Compound Library  |  Covalent Screening Library  |  Endocrinology Compound Library  |  Reparixin  |  Motixafortide  |  TAK-779  |  IT1t dihydrochloride  |  NBI-74330  |  Baohuoside I  |  AMD 3465 hexahydrobromide  |  ATI-2341 TFA  |  CXCR2-IN-1  |  FC131 TFA  |  ALX 40-4C Trifluoroacetate  |  SRT3109  |  PS372424 hydrochloride  |  SRT3190  |  VUF11207 fumarate  |  UNBS5162  |  CXCR7 modulator 1  |  Nicotinamide N-oxide  |  SB-265610  |  Antileukinate  |  Corydalmine  |  CTCE-9908  |  MSX-127  |  MSX-130

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。